Skip to main content

Elacestrant Disease Interactions

There is 1 disease interaction with elacestrant.

Moderate

Elacestrant (applies to elacestrant) liver dysfunction

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease

Avoid the use of elacestrant in patients with severe hepatic impairment (Child-Pugh C). The dose should be reduced in patients with moderate hepatic impairment (Child-Pugh B). No dosage adjustment is
recommended for patients with mild hepatic impairment (Child-Pugh A).

References (1)
  1. (2022) "Product Information. Vancocin (vancomycin)." Aspen Pharmacare Australia Pty Ltd

Switch to consumer interaction data

Elacestrant drug interactions

There are 291 drug interactions with elacestrant.

Elacestrant alcohol/food interactions

There is 1 alcohol/food interaction with elacestrant.

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer